Publications

2016
25 January

Civil Society Has No Confidence in Stalled Framework for Engagement with Non-state Actors Process
2015
23 December

PRIME Example of How EMA is Pushing for Accelerated Market Approvals
3 December

Trilogue Negotiations on Commission’s Proposal for Trade Secrets Directive
1 December

Medicines Transparency Alliance (MeTA) Evaluation
19 November

Global Snakebite Initiative Appoints Health Action International as Secretariat
27 October

Multi-sectoral NGO Coalition Calls on Parliament to Defend Safeguards for Consumers, Journalists, Whistleblowers, Public Authorities and Workers
16 October

“Adaptive Licensing” or “Adaptive Pathways”: Deregulation Under the Guise of Earlier Access
16 October

NVTG Congres richt zich op toegang tot geneesmiddelen
14 October

Empty Gestures – The EU’s Commitments to Safeguard Access to Medicines
14 October

HAI and MSF Report Shows European Commission’s Access to Medicines Commitments are ‘Empty Gestures’
30 September

EU medicines policy & access to medicines
30 September

Early Access to Medicines Marketing Authorisation Flexibilities Should Only Respond to Unmet Medical Needs, Must Protect Patient Safety
16 September

Direct Patient Reporting in the EU: A Snapshot of Reporting Systems in Seven Member States
18 August

Declaration of Public Interest Regarding Access to Imatinib (Glivec) in Colombia
8 July

Health Action International Opposes European Parliament’s ISDS Compromise in TTIP
7 July

EU Medicines Policy and Access to Medicines
2 July

Health Groups Call on European Medicines Agencies to Address Independence and Transparency Problems
29 June

HAI Sexual Harassment Policy
24 June

We Need a Reponsible R&D Model
23 June

Health Action International Launches New Brussels Office
16 June

Health Action International Criticises JURI Support for EU Trade Secrets Directive Report
15 June

End of Transparency: Paving the way for Trade Secrets in TTIP
14 April

How TTIP Could Damage Access to Affordable Medicines in the European Union
23 March

EU Trade Secrets Directive Threat to Free Speech, Health, Environment and Worker Mobility
15 March

Assessing the Nature, Extent and Impact of Regulation of Medicines Promotion
3 March

2014 Annual Report and Financial Statements
1 March

2014 Annual Report and Financial Statements
1 March

Donors
18 February

EU Clinical Trials Regulation: EMA Steers Away from Transparency by Misinterpreting Exception Provisions
4 February

The EU-US trade deal could leave Europeans sick